Catalyst Pharmaceuticals (CN2.F) Q2 2026 Earnings

May 11Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.29
0.33
0.38
0.42

Details

Expected EPS
0.40327025
Actual EPS
0.424495
Surprise EPS
0.02
Surprise Percent
+5.26%

Description

⁨Catalyst Pharmaceuticals⁩ (⁦CN2.F⁩) has reported earnings of ⁦0.424495⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts